Related Experiment Video
Updated: Jan 31, 2026

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
Published on: February 17, 2023
Surgical options for glycaemic control in Type 1 diabetes
K T D Yeung1,2, M Reddy2,3, S Purkayastha1,2
1Department of Surgery and Cancer, Imperial College, London, UK.
Surgical options are emerging for Type 1 diabetes management, offering potential improvements beyond traditional methods. While bariatric surgery is established for Type 2 diabetes, its role in Type 1 diabetes is still under investigation.
Area of Science:
- Endocrinology and Metabolic Diseases
- Surgical Innovation
- Diabetes Management
Background:
- Type 1 diabetes presents significant management challenges.
- Bariatric surgery is highly effective for Type 2 diabetes and obesity.
- Surgical interventions for Type 1 diabetes are not yet established.
Purpose of the Study:
- To review current surgical options for Type 1 diabetes.
- To explore technological advancements in diabetes care.
- To discuss the potential and controversies of surgical interventions in Type 1 diabetes.
Main Methods:
- Review of current literature on surgical interventions for Type 1 diabetes.
- Discussion of implantable continuous glucose monitoring.
- Analysis of continuous intraperitoneal insulin infusion pumps and closed-loop systems.
Main Results:
- Continuous glucose monitoring and insulin pumps are advancing treatment.
- Closed-loop systems (artificial pancreas) integrate monitoring and delivery.
- Bariatric/metabolic surgery is considered, though controversial for Type 1 diabetes.
Conclusions:
- Surgical interventions show promise for optimizing Type 1 diabetes treatment.
- Technological advancements are expanding therapeutic possibilities.
- Further research is needed to establish the role of surgery in Type 1 diabetes management.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Psychoneuroimmunology: Diabetes and Cancer

